LY86 and diabetic cardiomyopathy: Furthermore, MD1, a negative regulator of TLR4, when deleted, enhances AF susceptibility and induces atrial remodeling in diabetic cardiomyopathy mice through activation of the TLR4/NF-κB signaling pathway (Shi et al., 2023).